Cited by

• The University of Wisconsin Breast Cancer Epidemiology Simulation Model: An Update.

  Alagoz O, Ergun MA, Cevik M, Sprague BL, Fryback DG, Gangnon RE, Hampton JM, Stout NK, Trentham-Dietz A. Alagoz O, et al. Med Decis Making. 2018 Apr;38(1_suppl):99S-111S. doi: 10.1177/0272989X17711927. Med Decis Making. 2018. PMID: 29554470 Free PMC article.
• Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy.

  Chen WT, Lee CC, Goldstein L, Bernier S, Liu CH, Lin CY, Yeh Y, Monsky WL, Kelly T, Dai M, et al. Chen WT, et al. Breast Cancer Res Treat. 1994;31(2-3):217-26. doi: 10.1007/BF00666155. Breast Cancer Res Treat. 1994. PMID: 7881100 Review.
• Vitamin D receptors in breast cancer cells.

  Buras RR, Schumaker LM, Davoodi F, Brenner RV, Shabahang M, Nauta RJ, Evans SR. Buras RR, et al. Breast Cancer Res Treat. 1994;31(2-3):191-202. doi: 10.1007/BF00666153. Breast Cancer Res Treat. 1994. PMID: 7881099
• Differential expression of steroid receptors, hsp27, and pS2 in a series of drug resistant human breast tumor cell lines derived following exposure to antitumor drugs or to fractionated X-irradiation.

  Whelan RD, Hill BT. Whelan RD, et al. Breast Cancer Res Treat. 1993;26(1):23-39. doi: 10.1007/BF00682697. Breast Cancer Res Treat. 1993. PMID: 8400321
• Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression.

  Wolf C, Rouyer N, Lutz Y, Adida C, Loriot M, Bellocq JP, Chambon P, Basset P. Wolf C, et al. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1843-7. doi: 10.1073/pnas.90.5.1843. Proc Natl Acad Sci U S A. 1993. PMID: 8446598 Free PMC article.